caffeine and s20098
caffeine has been researched along with s20098 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bogatko, K; Kukuła-Koch, W; Poleszak, E; Serefko, A; Szopa, A; Wlaź, P; Wośko, S; Wróbel, A; Wyska, E | 1 |
| Doboszewska, U; Dudka, J; Herbet, M; Jedynak, S; Juś, P; Korga, A; Ostrowska, M; Poleszak, E; Serefko, A; Świąder, K; Szopa, A; Wlaź, A; Wlaź, P; Wyska, E | 1 |
Other Studies
3 other study(ies) available for caffeine and s20098
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Caffeine augments the antidepressant-like activity of mianserin and agomelatine in forced swim and tail suspension tests in mice.
Topics: Acetamides; Animals; Antidepressive Agents; Caffeine; Drug Therapy, Combination; Hindlimb Suspension; Male; Mianserin; Mice; Motor Activity; Swimming | 2016 |
Withdrawal of caffeine after its chronic administration modifies the antidepressant-like activity of atypical antidepressants in mice. Changes in cortical expression of Comt, Slc6a15 and Adora1 genes.
Topics: Acetamides; Amino Acid Transport Systems, Neutral; Analysis of Variance; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Caffeine; Catechol O-Methyltransferase; Cerebral Cortex; Gene Expression Regulation; Hypnotics and Sedatives; Locomotion; Male; Mianserin; Mice; Receptor, Adenosine A1 | 2018 |